Abnova is the world's largest antibody and recombinant protein manufacturer. Rather than the traditional method of monoclonal antibody production, Abnova is taking a genomic/proteomic approach for the antibody development.
Abnova is the first biotech company successfully integrated the IT-style management and industrial-scale antibody manufacturing. Abnova's goal is to have at least one antibody to every human expressed gene in the human genome.
Abnova manufactures all products of recombinant proteins and antibodies, in-house in their state-of-the art facility. They have implemented an unique platform for immunizing full-length native proteins to generate MaxPab® polyclonal antibody.
They also have multiple clones for their monoclonal antibodies, of which their access is available to customers and partners from academics, research institutions, biotech and pharmaceutical companies.
Advanced Biotechnologies Inc (ABI) is recognized as The Virology Resource Centre™. ABI specializes in the development and manufacturing of products for the research diagnosis, monitoring, and treatment of infectious diseases.
ABI's expertise are HIV, HTLV, HSV, VZV, EBV, CMV, HHV-6, HHV-7, HHV-8, RSV, SIV, Rubella, Influenza, Vaccinia, Chlamydia, Neisseria and Toxoplasma.
Arbor Assays' company philosophy is to build the highest quality detection and immunoassay products for clinically important biomolecules.
Their primary customer focus is both pharmaceutical and clinical scientists. Arbor Assays builds robust immunoassay and enzyme activity kits to quantitate biomolecules in biological matrices, and finds delight in taking on the most technically challenging assays there are to develop.
Arbor Assays' products fall into three general areas:
ATCC is a private, nonprofit biological resource center (BRC) and research organization that focuses on the acquisition, authentication, production, preservation, development and distribution of standard reference microorganisms, cell lines and other materials for research in the life sciences.
Biomedal S. L. is a biotechnology company devoted to the development and commercialization of products and services for life sciences research, and technology for industrial bioprocesses. Their own technology has also allowed improvements in the field of recombinant protein production. They specialise in the following areas: Genetic Engineering, Protein Expression and Purification, Antibodies. Peptides and Proteins and in-vitro Diagnostics.
Cytoskeleton, Inc. offers a wide range of kits and products for drug screening, signal transduction and cytoskeletal research. We specialize in the production of purified proteins and easy-to-use kits to study biochemical and cellular processes. Our kits are either made for smaller number of samples for use in basic research or small screens (Biochem Kits™) or in a high throughput scale for large screens (CytoDYNAMIX Screens™). In addition to existing products, Cytoskeleton provides drug screening services for microtubules, tubulin and several other proteins in our product line.
Impress Yourself with the new Eppendorf Cell Culture Consumables!
Proven Eppendorf quality brought to a new level.
Premium in all aspects: Product, Performance and Packaging.
ESI BIO's mission is to be their customer's trusted partner in translating scientific discoveries to the clinic. They do this by providing breakthrough stem cell technologies as research grade and therapeutic grade products, lighting the path from research to the clinic in order to help their customers with their goal of treating disease.
A rich history with multiple locations, shared resources and shared goals. ESI BIO has been built upon a rich legacy of innovation and scientific firsts. They were established in Singapore as ES Cell International in 2000 where they made history by manufacturing the first translatable clinical grade embryonic stem cell lines for distribution to the international research community.
Antibodies, Purified Antigens and Specialty Research Products You Can Depend On
Fitzgerald Industries International (FII) is the premier worldwide supplier of 35,000 products, including antibodies, antigens, ELISA kits and specialty research products to commercial diagnostic companies and research institutions. Customers around the world depend on FII products for projects including Lateral Flow, ELISA (Enzyme-Linked Immunosorbent Assays), RIA (Radioimmunoassay), Immunoblotting, Immunohistochemistry and Flow Cytometry. Visit www.fitzgerald-fii.com for a huge range of products.
GeneTex, Inc started operations in early 1997, founded by 3 internationally known scientists with recognised expertise in oncology and infectious diseases. The initial focus was on a portfolio of reagents that met the needs of researchers working to find out what causes cancer, how it can be better diagnosed and related studies. They have since added tools for scientists studying basic mechanism common to many forms of cancer; tools such as immunological reagents used to study specific proteins and events involved in the regulation of the cell cycle and DNA repair and replication.
J R Scientific is a pioneer in the manufacture of classical and custom cell culture media and sera products on a direct basis and under special OEM contracts with other suppliers. J R Scientific, Inc. was the first to provide the industry with large-scale powdered media, low protein serum-free hybridoma and insect cell culture media, and bulk liquid media transfer systems.
Lifeline Cell Technology is a wholly-owned subsidiary of International Stem Cell Corporation (ISCO). They supply pharmaceuticals, academic and government scientists with high-quality human primary cells, stem cells, media and reagents back by over 20 years combined experience in research, development, manufacturing, quality control, marketing and sales for human cell culture products.
Polyplus-transfection is focused on developing reagents for intracellular delivery of biomolecules. Its expertise includes in vitro and in vivo delivery of genes, oligonucleotides, siRNA and proteins.
With over half its revenues reinvested into R&D, Polyplus-transfection covers all aspects including the physical chemistry, cell biology and pharmacology of carriers. This leads to constant improvement of existing solutions as well as original compounds at the forefront of delivery science.
R&D Systems was founded and incorporated in 1976 in Minneapolis, Minnesota and was acquired by TECHNE in 1985.
R&D Systems' Biotechnology division manufactures reagents primarily for the research market. In 1985 R&D Systems entered the research reagent market with its first cytokine, TGF-beta1, which was purified from porcine platelets. R&D Systems was the first company in the world to release TGF-beta1 commercially. Subsequently several other cytokines were purified and released to the research market.
Encouraged by its success in the cytokine market, in 1988 R&D Systems formed its Biotechnology Division with the goal of producing and marketing a wide range of human cytokines through genetic engineering. In 1989 the Biotechnology Division began developing monoclonal and polyclonal antibodies to cytokines and in 1990 it developed its first enzyme-linked immunosorbent (ELISA) assay kit. Today, R&D Systems is the world's leading supplier of research and diagnostic cytokine products and manufactures over 20,000 products.
R&D Systems is committed to the highest level of quality in the manufacture, sale and support of their products. Further, R&D Systems, Inc. is joining Tocris Bioscience (www.tocris.com) and Boston Biochem, Inc. (www.bostonbiochem.com) to offer the highest quality research reagents on the market.
Zen-Bio, Inc. (ZB) is a leading provider of research tools for the study of human metabolic disease. The company, founded in 1995, performs contract research for major pharmaceutical and biotechnology companies around the world.
The company pioneered tissue engineering with adult adipose-derived stem cells and is currently researching the role obesity plays in the development and on-set of metabolic disease.
ZB's mission is to provide the highest quality cell, reagents and contract services to the biomedical research community; to develop and commercialize research tools and to leverage our expertise in this field into successful treatments for metabolic diseases through research and development strategic alliances.
ZeptoMetrix Corporation (ZMC) brings together some of the world's leading scientists in the fight against infectious diseases. They have an extensive range of research products and services that is continuously expanding. Their mission - "Partner to our Customer" forms the basis of their successful collaboration with scientists globally.